Introduction
In many cases, hematopoietic SCT (HSCT) is the therapy of choice for patients with malignant hematologic diseases. 1, 2 For roughly one third of the patients, a histocompatible family donor is available. Therefore, a search for a matched unrelated donor (MUD) is necessary for the remaining two thirds of the patients. Much effort has been put into the worldwide organization of donor searches since establishing the feasibility of HSCT from a MUD. In recent years, comparable results in sibling and MUD HSCT have been reported. [3] [4] [5] [6] [7] In a small country where the pool of national donors is limited, a large majority of the donors must be obtained from the international donor pool outside the country. Sophisticated worldwide computer networks are available for the provision of MUDs from all around the world. About 15 million international HSCT donors are registered 8 in a network of interconnected national hubs (National Haematopoietic Stem Cell Donor Registries), where the data of the national donors is stored electronically. Two large computer networks-BMDW (Bone Marrow Donors Worldwide) and EMDIS (European Marrow Donor Information System)-connect the national hubs. BMDW gives the search coordinator an overview on the number and quality of HLA typing of donors for a certain patient. EMDIS also provides donor data and, in addition, helps the user with the logistics of an international donor search.
Since 1988, the Austrian Bone Marrow Donor Registry has been the central search coordinating unit in charge of national and international donor searches in Austria. We have analyzed the search data from the last 20 years using multivariate analyses in order to assess patients' chances and risks-currently and in the past-for finding a MUD. This analysis should also be used to identify areas for improvement.
Patients and methods

Patients
Characteristics of patients for whom international donor searches have been performed. All Austrian patients in need of an unrelated HSCT donor and for whom a MUD search was performed and completed between 1988 and 2007 were included in this retrospective analysis. Patients with still ongoing searches-where neither an official search stop order nor any other similar information had been received from the transplant center-were excluded from the analysis. Their number was 151. A further 88 patients with very recently started searches-between 30 September 2007 and 31 December 2007-were also excluded. Thus, a total of 239 patients with current ongoing searches were not included in the analysis. The total number of patients analyzed is 1586 as shown in Table 1 . Of those, 389 patients were children up to 18 years, who were treated in pediatric departments, while 1197 patients were adults. MUD searches were always searches for both national and international donors.
Patients' characteristics are depicted in Table 1 . The time frame under analysis has been subdivided into two periods of equal length and a shorter period according to the point in time when the patients' search started. The reasons for choosing these three periods are as follows: From 1 January 1996, onwards, serological HLA class I typing for donor selection was replaced by intermediate resolution DNA typing for HLA class I. In addition, high resolution DNA typing for HLA class II has been used for final donor selection.
The routine use of high resolution DNA typing of patients and donors for both HLA class I and HLA class II started from 1 January 2004.
been grouped into 'Northwest European or Middle European patients'. As Austria is home to a large minority (6.7% nationwide) of people originally from the former Yugoslavia or from Eastern Europe, this minority is also present among the patients. Another minority living in Austria is from Turkey (1.6% with Turkish nationality in Austria). Both minorities-the East and Southeast European group as well as the Turkish group-immigrated to Austria between 1950 and the present time. 9 These minority groups can also be found among our patients. In all, 6.3% of the patients were from East or Southeast Europe, while 2.1% of the patients were of Turkish origin. As patients from outside the European continent are also sometimes treated in Austria, a group of non-European individuals can also be found among our patients (2.7%). Pertinent numbers are detailed in Table 1 After the receipt of the formal order accompanied by the tissue type, the international donor search is immediately started in accordance with published guidelines and procedures. 10 As soon as the official search order is received, the BMDW computer system is contacted in order to obtain an overview of available donors in the international donor pool. In the meantime, an international request goes out electronically via EMDIS or other means to the international registries. Donors with the best matching tissue type in the highest resolution available are selected for confirmatory typing irrespective of their nationality. High resolution confirmatory HLA typing of patient and donor and the cross match test are performed in the tissue typing laboratory of the transplant center. When the result of confirmatory typing, age, gender and nationality of the donors are known, the attending physician of the transplant center decides which donor will be selected and sets the date for transplant. Donor work-up is, again, organized by the Austrian Registry.
Tissue typing and the donor selection process. During search period I, HLA typing involved serological HLA-A, -B, -C (HLA class I) typing, as well as DNA-based low resolution typing of HLA-DRB1 and -DQB1 (HLA class II) alleles. MLC testing was performed until 1992 and stopped afterwards; similarly, RFLP typing was performed until 1992. Serological split typing of patient and donor for HLA class I determinants and the DNA-based 18,19 the 10 most frequent HLA haplotypes have been found to be the 'top ten' in at least two different large independent Caucasoid population samples. We have also classified patients as having a 'common HLA phenotype' when they had at least one of the 10 most frequent HLA haplotypes, as described. 20, 21 In all, 261 patients had one or two of these common haplotypes.
Data collection. The Austrian Bone Marrow Donor
Registry keeps track of all international donor searches that have been performed over the years, including lab reports, shipment protocols and international contacts, in hard copies, fax copies or electronic format. These documents were used for data collection.
Statistics. In order to determine the risks of remaining without a transplant and the chances of a successful donor search, we performed multivariate analyses of the factors that might influence the probability of finding a donor and the likelihood of ultimately receiving a transplant.
Counts, percentages and medians are provided for basic data description purposes.
The lengths of time elapsed from search start to acceptance of a donor and from search start to transplantation were treated as right censored data, and in both cases death was regarded as a competing risk. For these characteristics, cumulative incidence curves are provided.
The prognostic impact of different characteristics on censored data was estimated with Kaplan-Meier product limit estimates 22 and tested with the logrank Mantel-Cox test, accounting for competing risk by adaptation of the censoring time. For multivariate analyses, Cox-PH models were constructed, and parameter estimates and P-values are shown. 23 Distributional differences of rank data were analyzed with the Kruskal-Wallis Rank Sum test ('rank analysis of variance'). Correlations between rank data and time were quantified with Kendall's Tau and the corresponding test.
The level of significance used was a ¼ 0.05 (two sided). The study being exploratory in nature, no adjustment for multiple testing was applied. All calculations were performed with the open source statistical computing environment R. 24 For censored data, the survival package was used. 25 Table 1 .
Results
Patients
In general, the annual number of patients, for whom a search was started, has increased. However, in the latest period, a decrease in pediatric patients was observed. Although the median age of adult patients increased over the years, there was no change in the median age of children. More boys than girls were searched for during all periods-also in adults, there were slightly more males than females. In adult patients, the percentage with non-Western or non-Middle European origin rose from 6.5 to 8.3% from period I to period III, whereas in children, an increase from 15.3 to 32.7% was seen. In adults, MUD searches for the indications AML, myelodysplastic syndrome and lymphoma increased markedly, whereas for CML, the number of searches decreased substantially. In pediatric patients, a marked decrease in MUD searches was recorded for the indications CML and ALL, whereas the searches for lymphoma and congenital diseases increased (Table 1) . A decrease of searches for patients with severe aplastic anemia both in adults and in children could be seen (Table 1) .
Time elapsed between diagnosis and search start. We noted that the time between diagnosis and search start can vary strongly between patients. The time frame between diagnosis and search start generally became shorter over time, although this development was more pronounced with adults than with children (Table 1) .
Overall results. Overall results are shown in Table 2 . The number of patients for whom a compatible donor could be found increased from 53.4% in period I to 76.7% in period III (Table 2) . A similar increase was observed for patients who were transplanted. Their percentage rose 29 .6% in period I to 61.6% in period III. Thus, the percentage of patients who had a donor and were transplanted has grown strongly over time and is now, in the last period, at over 60%. However, a remarkable percentage of patients remained without transplant because no suitable donor was available, even in period III: 23.3%. In all, 17.5% died without a donor in period III. Another group of patients was not transplanted, although a matching donor had been identified (15.1% in period III).
Search times for international donors have dramatically decreased in recent years. Although it took several months to find a donor in early search periods, the median search time in period III was 1.7 months for patients who had a donor.
Overall results per year. In Figure 1 , data is broken down by year. Although in 2006 and 2007, 63.7 and 63.9% of the patients could be transplanted with a matching donor, 14.5 and 16.7% of patients died without a donor and 15.5 and 6.9% of patients died even though a donor had been identified.
Results for patients of different national origins. Table 3 shows that as a general rule, patients from Western and Middle Europe and from East and Southeast Europe (69.2 and 72.0%) had better chances of finding a donor than patients from Turkey and from non-European countries (63.6 and 55.8%). This trend is especially apparent in period III. Donor searches for patients from Western and Middle Europe and from East and Southeast Europe had a success rate of 76.6 and 83.3%, respectively, in period III. The success rate for patients originating from Turkey and from outside Europe was lower: 75.0 and 60.0% in period III.
Multivariate analyses
Results of the multivariate analyses of the factors that might influence the probability of finding a donor are shown in Table 4 . The following patient factors were the basis of this analysis: age, gender, region of origin, diagnosis, common or non-common HLA phenotype, time between diagnosis and search start and period of time during which the search was started.
Most importantly, starting a MUD search in later years significantly increased the likelihood of finding a matching donor and being transplanted (Po0.0001). Patients' chances of both finding a suitable donor and receiving a transplant increased year over year.
In addition, the multivariate analyses determined that the factor influencing the identification of a matching donor is having a common HLA phenotype (Po0.0001). A patient's European origin (P ¼ 0.029) and a shorter time between diagnosis and search start (P ¼ 0.005) were the factors that most strongly influenced a patient's access to a transplant. Chance of finding a matched unrelated donor A Rosenmayr et al
Search duration
In Figures 2a-d , an incidence curve shows the influence of some of the above mentioned variables on search times: Figures 2a and b show that the duration of searches, as well as the duration until transplant, continuously decreased from search period to search period. Having a common HLA phenotype positively influenced the search for a donor (see Figure 2c) . Figure 2d shows the positive influence of a short time interval between diagnosis and search start on the chance of being transplanted.
Discussion
As shown in this study, in 2006, a suitable donor could be identified for 81.9% of our patients, whereas in 2007, the search was successful for 75% of patients (see Figure 1) . During the last 20 years, a donor could be found for 68.9% of the patients (see Table 3 ). During the last period, from 2004 to 2007, a suitable MUD could be identified in 76.7% of patients in need (see Table 3 ). Search duration has decreased dramatically from many months in early years to currently 1.7 months. Searching for patients of European descent yields the highest success rate: in the latest period, from 2004 to 2007, for 76.6% of West and Middle-European patients, a donor could be identified, as well as for 83.3% of patients of East and South-East European origin. Searches for patients from Turkey and other countries outside Europe were not as successful as searches for patients of European descent: from 2004 to 2007, there was a matching donor for 75% of patients from Turkey and for 60% of non-European origin (see Table 3 ).
The data obtained in this study support data published by other researchers. For instance, Heemskerk et al. 20 reported that, during the last years, an unrelated donor could be found for 84% of a patient population that was mainly Dutch. However, only for 59% of patients of nonNorthwestern European descent, the Dutch group was able to find suitable donors. The search times recorded by Heemskerk et al. are also comparable to ours, as the median search time for Northwestern European patients in the Netherlands was 1.5 months. In our analysis, the median search time for successful searches is 1.7 months.
Unfortunately, not all patients with an identified donor have been transplanted. In both 2006 and 2007, about 64% of patients received a transplant (Figure 1 ). This means that, in spite of the availability of a matching donor, 18.2% of patients did not receive a transplant in 2006, whereas in 2007, 11.1% of patients were not transplanted. Tragically, the majority of the patients with a matching donor who were not transplanted in 2006 and 2007 passed away. In 2006, it was 15.5% and in 2007, it was 6.9% ( Figure 1) . The data is also comparable to our Dutch colleagues' data. In the Dutch study, it was also found that a significant percentage of patients become medically unfit for transplantation in spite of the presence of a matching donor. 8, 20 An analysis of search times (Table 2) showed that patients who had a donor but were not transplanted had a significantly longer search time than patients who were given a transplant. The multivariate analyses (Table 4) showed that not proceeding to transplant is associated most significantly with two factors; namely being non-European and having a long time period between diagnosis and search start. We speculate that especially in cases where transplant physicians were hesitant to start an international search early after diagnosis and when, in addition, the duration of the search was longer than expected-possibly due to the patient's unusual HLA type or due to another problem emerging during search-patients are at risk for becoming medically unfit for transplantation during the (Table 2) . Again, West and Middle Europeans have better chances of receiving a transplant, as only 23.4% of those patients did not have a donor. Turkish and nonEuropean patients' chances are significantly lower: 25.0 and 40.0% had no suitable donor in the latest period of this study ( Table 3 ). The subgroup of patients from Turkey is small, however, so it cannot be ascertained if the effectsin the statistical sense-are equal.
The percentage of patients with no donor is relatively small-especially among European patients-but has, unfortunately, not changed significantly during the last years Table 2 ). We speculate that in these patients, specific combinations of rare HLA determinants occur, making their HLA phenotypes almost unique. Several analyses performed recently by Tiercy et al. 19, 21 have shown that certain rare combinations of rare HLA determinants often occur in patients for whom it is difficult or impossible to identify a matching donor. In addition to that, Tiercy et al. even developed an algorithm for predicting a specific patient's chances of identifying a matching donor. 19, 26 First, analyses of our respective data confirm these data (Rosenmayr et al., in preparation). When the search for a MUD fails, other options remain for a patient: a related transplant with a haploidentical donor or a transplant with unrelated cord blood. Both are, however, more risky than a transplant from a suitable MUD donor.
1 Both options should be offered to the transplant physician as soon as it becomes evident that the patient has only a low chance to find a completely matching donor.
In conclusion, a patient's chances of finding a suitable MUD were 81.9% in 2006 and 75.0% in 2007 (Figure 1) . European patients had better chances, while patients from Turkey and other non-European countries had a worse chance of finding a donor. In our analysis, patients from East and Southeast Europe seemed to have slightly better chances to find a donor than patients form West and Middle Europe. Maybe the reason is that a major part of the donors from the world's two biggest registries (Germany and USA) has ancestors from Eastern Europe. These individuals possibly represent the donor source for our patients from East and Southeast Europe.
We had to exclude 239 patients from the study: 151 patients-33 children, 118 adults-because we never had received an official search stop information and also because any other similar information on the patients was not available. In addition, we actively excluded 88 patients, where international search had just been started between 1 and 3 months before the end of the study period. The nationality of the excluded patients was Table 3 The probability of finding a donor for all patients, overall and in period III 
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